GW Pharmaceuticals Revenue
What is the Revenue of GW Pharmaceuticals?
The Revenue of GW Pharmaceuticals is $559.038M
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with revenue similar to GW Pharmaceuticals
- InvoCare has Revenue of AUD$556.971M
- Monarch Networth Capital has Revenue of ₨557.404M
- Select Interior Concepts has Revenue of $557.434M
- Allied Motion Technologies Inc has Revenue of $557.799M
- W & T Offshore Inc has Revenue of $558.295M
- Mercury Laboratories has Revenue of ₨558.716M
- GW Pharmaceuticals has Revenue of $559.038M
- Comfort Intech has Revenue of ₨559.090M
- Nine Service Inc has Revenue of $559.211M
- Bel Fuse has Revenue of $559.987M
- Bel Fuse has Revenue of $559.987M
- Global Eagle Entertainment has Revenue of $559.997M
- Rotork Plc has Revenue of £560.913M